Showing results (191-200 of 229) with videos related to
Sort By:
Pageof 23
Cancer Prevention Research (Philadelphia, Pa.)|August 23, 2014
Folate and vitamin B12 may play a critical role in lowering the HPV 16 methylation-associated risk of developing higher grades of CINChandrika J Piyathilake, Maurizio Macaluso, Michelle M Chambers, et al.Human Pathology|November 11, 2003
Expression of CEA, Tag-72, and Lewis-Y antigen in primary and metastatic lesions of ovarian carcinomaDavid C Chhieng, Cristina Rodriguez-Burford, Lynya I Talley, et al.Cancer|March 24, 2010
Cervical cancer prevention: new tools and old barriersIsabel C Scarinci, Francisco A R Garcia, Erin Kobetz, et al.Journal of the American Chemical Society|April 25, 2014
Homochiral columns constructed by chiral self-sorting during supramolecular helical organization of hat-shaped moleculesCécile Roche, Hao-Jan Sun, Margaret E Prendergast, et al.Journal of the American Chemical Society|April 2, 2015
Increasing 3D Supramolecular Order by Decreasing Molecular Order. A Comparative Study of Helical Assemblies of Dendronized Nonchlorinated and Tetrachlorinated Perylene BisimidesBenjamin E Partridge, Pawaret Leowanawat, Emad Aqad, et al.Gynecologic Oncology|November 1, 1994
LLETZ is an acceptable alternative to diagnostic cold-knife conizationR W Naumann, M C Bell, R D Alvarez, et al.Journal of the American Chemical Society|December 31, 2014
Complex columnar hexagonal polymorphism in supramolecular assemblies of a semifluorinated electron-accepting naphthalene bisimideYu-Chun Wu, Pawaret Leowanawat, Hao-Jan Sun, et al.Gynecologic Oncology|February 1, 1994
Prospective randomized trial of LLETZ versus laser ablation in patients with cervical intraepithelial neoplasiaR D Alvarez, C W Helm, R P Edwards, et al.Gynecologic Oncology|July 1, 1992
The prognostic implications of low serum CA 125 levels prior to the second-look operation for stage III and IV epithelial ovarian cancerH H Gallion, J E Hunter, J R van Nagell, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996
Intraperitoneal radioimmunotherapy of ovarian cancer with lutetium-177-CC49R F Meredith, E E Partridge, R D Alvarez, et al.Pageof 23